Growing community of inventors

Redwood City, CA, United States of America

Michael Martin Ollmann

Average Co-Inventor Count = 4.05

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 13

Michael Martin OllmannDavid J Matthews (2 patents)Michael Martin OllmannTimothy S Heuer (2 patents)Michael Martin OllmannAlison Joly (2 patents)Michael Martin OllmannLynn Margaret Bjerke (2 patents)Michael Martin OllmannKevin Patrick Keegan (2 patents)Michael Martin OllmannThomas J Stout (2 patents)Michael Martin OllmannMark E Maxwell (2 patents)Michael Martin OllmannChunyan Song (1 patent)Michael Martin OllmannBenjamin C Hitz (1 patent)Michael Martin OllmannMichael Martin Ollmann (5 patents)David J MatthewsDavid J Matthews (23 patents)Timothy S HeuerTimothy S Heuer (12 patents)Alison JolyAlison Joly (10 patents)Lynn Margaret BjerkeLynn Margaret Bjerke (9 patents)Kevin Patrick KeeganKevin Patrick Keegan (4 patents)Thomas J StoutThomas J Stout (3 patents)Mark E MaxwellMark E Maxwell (2 patents)Chunyan SongChunyan Song (1 patent)Benjamin C HitzBenjamin C Hitz (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Exelixis, Inc. (5 from 173 patents)


5 patents:

1. 8758994 - CDK9 as modifier of the IGF pathway and methods of use

2. 8288119 - PGDS as modifiers of the PTEN pathway and methods of use

3. 7927872 - ALDOs as modifiers of the IGF pathway and methods of use

4. 6630297 - Methods of screening for agents that modulate the interaction of human ECT2 polypeptide with an ECT2 binding target

5. 6515109 - Human ECT2 polypeptide

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/7/2025
Loading…